Product Information
MULTAQ 400 MG TABLET is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $13.1865 per EA under NDC 00024414260. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 1, 2009.
Strength
400 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024414260
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DRONEDARONEApproval Type
New Drug (NDA)
FDA Application
NDA022425FDA Approved
7/1/2009
On Market Since
7/1/2009
Pharmacological Classes
Price Statistics
The NADAC for MULTAQ 400 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 137.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.1865 per EA |
|---|---|
| All-time high | $13.1956 (Jun 10, 2026) |
| All-time low | $5.5634 (Nov 28, 2013) |
| 52-week high | $13.1956 |
| 52-week low | $12.9322 |
| Median price | $10.5125 |
| Average price | $10.4009 |
| Largest weekly change | +12.9% (Sep 17, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dronedarone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sanofi-Aventis U.S. LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dronedarone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MULTAQ 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MULTAQ 400 MG TABLET, manufactured by Sanofi-Aventis U.S. LLC, is $13.1865 per EA (NDC 00024414260), effective Sep 30, 2026.
How has the price of MULTAQ 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for MULTAQ 400 MG TABLET has risen 137.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MULTAQ 400 MG TABLET?
Since Nov 28, 2013, the NADAC for MULTAQ 400 MG TABLET has ranged from a low of $5.5634 (Nov 28, 2013) to a high of $13.1956 (Jun 10, 2026), with a median of $10.5125 per EA.
Are there cheaper alternatives to MULTAQ 400 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MULTAQ 400 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MULTAQ 400 MG TABLET?
MULTAQ 400 MG TABLET (NDC 00024414260) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.